[ Price : $8.95]
An Akin legal update says FDAs recent issuance of Warning Letters to four direct-to-consumer testing companies over the use of una...[ Price : $8.95]
FDA cites Nubratori Inc. for multiple manufacturing and contamination-control deficiencies following a December inspection of the ...[ Price : $8.95]
HHS Office of Inspector General issues new guidance clarifying when pharmaceutical manufacturers can sell prescription drugs direc...[ Price : $8.95]
FDA warns Malaysias Fulijaya Manufacturing about CGMP violations in its production of finished drugs.[ Price : $8.95]
A Friends of Cancer Research white paper explores the emerging role of AI-enabled tumor assessment tools and the framework needed ...[ Price : $8.95]
Roche says its experimental dual GLP-1/GIP receptor agonist CT-388 delivered substantial and statistically significant weight loss...[ Price : $8.95]
A Ropes & Gray year-end review examines significant changes in FDA and Justice Department enforcement actions pertaining to regula...[ Price : $8.95]
FDA lifts a clinical hold on Intellia Therapeutics MAGNITUDE-2 Phase 3 trial evaluating nexiguran ziclumeran for patients with her...